The circadian architecture of tumor immunity: mechanistic insights and treatment strategies
Open Access
- 24 July 2026
- journal article
- review article
- Published by Springer Nature in Biomarker Research
- Vol. 14 (1)
Abstract
No abstract availableKeywords
Funding Information
- Fundamental Research Funds for the Central Universities, HUST (No. YCIJ20252402)
- National Natural Science Foundation of China (No. 82373054)
- special Fund for Science and Technology Innovation of Hubei Province (No. SCZ202461)
This publication has 378 references indexed in Scilit:
- Simvastatin overcomes the pPCK1‐pLDHA‐SPRINGlac axis‐mediated ferroptosis and chemo‐immunotherapy resistance in AKT‐hyperactivated intrahepatic cholangiocarcinomaCancer Communications, 2025
- Patterns in Cancer Incidence Among People Younger Than 50 Years in the US, 2010 to 2019JAMA Network Open, 2023
- Disruption of the Clock Component Bmal1 in Mice Promotes Cancer Metastasis through the PAI‐1‐TGF‐β‐myoCAF‐Dependent MechanismAdvanced Science, 2023
- Tumor‐associated macrophages in liver cancer: From mechanisms to therapyCancer Communications, 2022
- Circadian Rhythm Disruption Increases Tumor Growth Rate and Accumulation of Myeloid‐Derived Suppressor CellsAdvanced Biology, 2022
- Gut microbiota–derived short‐chain fatty acids regulate group 3 innate lymphoid cells in HCCHepatology, 2022
- Increased dopamine and its receptor dopamine receptor D1 promote tumor growth in human hepatocellular carcinomaCancer Communications, 2020
- The aberrant expression of rhythm genes affects the genome instability and regulates the cancer immunity in pan‐cancerCancer Medicine, 2020
- Circadian rest‐activity rhythm as an objective biomarker of patient‐reported outcomes in patients with advanced cancerCancer Medicine, 2018
- Development of Small‐Molecule Cryptochrome Stabilizer Derivatives as Modulators of the Circadian ClockChemMedChem, 2015